<code id='9F45AEA72A'></code><style id='9F45AEA72A'></style>
    • <acronym id='9F45AEA72A'></acronym>
      <center id='9F45AEA72A'><center id='9F45AEA72A'><tfoot id='9F45AEA72A'></tfoot></center><abbr id='9F45AEA72A'><dir id='9F45AEA72A'><tfoot id='9F45AEA72A'></tfoot><noframes id='9F45AEA72A'>

    • <optgroup id='9F45AEA72A'><strike id='9F45AEA72A'><sup id='9F45AEA72A'></sup></strike><code id='9F45AEA72A'></code></optgroup>
        1. <b id='9F45AEA72A'><label id='9F45AEA72A'><select id='9F45AEA72A'><dt id='9F45AEA72A'><span id='9F45AEA72A'></span></dt></select></label></b><u id='9F45AEA72A'></u>
          <i id='9F45AEA72A'><strike id='9F45AEA72A'><tt id='9F45AEA72A'><pre id='9F45AEA72A'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:knowledge    Page View:113
          Judge's gavel
          Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

          WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

          Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

          advertisement

          Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          comprehensive

          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more
          Will generative AI in health care meet the fate of IBM's Dr. Watson?
          Will generative AI in health care meet the fate of IBM's Dr. Watson?

          MikeReddyforSTATThehealthcaresectorisanotoriouslaggardwhenitcomestotechnology.Itwasslowtousecomputer

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          States should stop sabotaging methadone treatment reform

          Somearguethattakingmethadoneathomeisfarbetterthantrudgingtoacliniceveryday.KevinD.Liles/APSincetheFo